期刊文献+

染色体3、7、17号和9p21位点在膀胱尿路上皮癌中的畸变情况及其临床意义 被引量:6

Aberrations of chromosomes 3,7,17 and 9p21 locus and its clinical significance in urothelial carcinoma of bladder
原文传递
导出
摘要 目的:应用UroVysion染色体及基因异常检测试剂盒,检测膀胱尿路上皮癌患者染色体3、7、17号和9号染色体短臂2区1带(9p21)位点的畸变情况,探讨这4种染色体畸变的临床意义及其组合辅助诊断膀胱癌的可行性。方法:采用UroVysion试剂盒中基因识别位点探针(LSI)9p21基因探针和着丝粒3、7、17探针(CEP3、CEP7、CEP17),以荧光原位杂交(FISH)检测60例膀胱癌患者和20例非肿瘤泌尿系疾病患者的新鲜尿液标本,统计分析每条染色体在膀胱癌患者中的畸变率及其与膀胱癌病理分期、分级间的关系,计算4种探针组合检测膀胱癌的总阳性率。结果:①用FISH法检测发现,60例膀胱癌患者的尿脱落细胞核中3、7、17号染色体及9号染色体p16基因均有较高的畸变率,分别为61.7%(37/60)、56.7%(34/60)、55.0%(33/60)及66.7%(40/60)。3、7、17号染色体畸变中,除3例患者表现为17号染色体单倍体,其余均表现为多倍体,各染色体畸变率在不同病理分级患者间差异有统计学意义(P<0.05),但在不同病理分期患者间差异无统计学意义(P>0.05)。9p21位点纯合性缺失者7例(11.7%),单体者22例(36.7%),多体者11例(18.3%),9p21的畸变率在不同病理分期、分级患者间差异均无统计学意义(P>0.05)。②60例膀胱癌患者4种探针组合检测的总阳性率为56.7%。20例非肿瘤泌尿系疾病患者中有2例FISH检测结果为阳性,特异度为90%。结论:我国人群中3、7、17号染色体和9p21位点畸变率很高,而其畸变与膀胱癌的早期发生、进展过程、恶性程度等密切相关。UroVysion试剂盒可在我国人群中开展应用,但其诊断灵敏度和特异度均较国外报道低。进一步寻找适用于国内膀胱癌的最佳探针组合,制定适当的阳性判断标准是非常必需的。 Objective To detect and analyze the aberrations of chromosomes 3,7,17 and 9p21 locus in urothelial carcinoma of bladder using the UroVysion chromosome and gene aberration detection FISH kit,and to investigate the clinical significance of these four chromosome aberrations and the feasibility of using these aberrations for helping the diagnosis of urothelial carcinoma of bladder.Methods The newly voided urine specimens of 60 cases of urothelial bladder carcinoma patients and 20 cases of non-cancer urinary tract disease patients were examined by FISH using the locus specific identifier(LSI) probe 9p21 and centromere enumeration probe(CEP) 3,7,17 in the UroVysion kit to analyze the correlation between aberration of chromosome and pathological stage and grade of urothelial bladder carcinoma and the overall detection rate of urothelial carcinoma by tests using these four probes.Result ① The aberration rates of chromosomes 3,7,17 and 9p21 in voided urine cells from the 60 bladder cancer patients were 61.7%(37/60),56.7%(34/60),55.0%(33/60) and 66.7%(40/60),respectively.Of the chromosome 3,7,17 aberrations,all were aneuploidy except the 3 cases of chromosome 17 monoploidy.The aberrations of chromosome 3,7,17 had no correlation with pathological stage(P〈0.05),but had significant correlation with pathological grade(P〈0.05).Rates of homozygous deletion,monoploidy,and polyploidy in 9p21 were 11.7%(7/60),36.7%(22/60),18.3%(11/60),respectively.The aberration of 9p21 had no correlation with pathological stage and grade(P〉0.05).② The sensitivity of using 4 chromosome probes for detecting bladder cancer was 56.7%(34/60);two cases of the 20 non-cancer urinary tract disease showed positive FISH results,therefore the specificity was 90%.Conclusions The aberration rates of chromosomes 3,7 and 17 are high in Chinese population.Chromosome aberrations are correlated with growth,development,and degree of malignancy of bladder cancer.UroVysion kit could be used as an non-invasive method for helping the diagnosis of urothelial carcinoma of bladder.But the sensitivity and specificity in Chinese patients are lower than that reported in Western countries.It is necessary to search for the best probe set and establish a positive standard for detecting urothelial carcinoma of bladder in Chinese patients.
出处 《诊断学理论与实践》 2012年第1期47-51,共5页 Journal of Diagnostics Concepts & Practice
关键词 膀胱尿路上皮癌 荧光原位杂交 染色体畸变 诊断 Urothelial carcinoma of the bladder Fluorescence in situ hybridization Chromosome aberration Diagnosis
  • 相关文献

参考文献15

  • 1Richter J, Jiang F, Gorog JP, et al. Marked genetic dif- ferences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hy- bridization[J]. Cancer Res,1997,57(14):2860-2864.
  • 2Bittard H, Lamy B, Billery C. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytome- try in bladder cancer[J]. J Uro1,1996,155(6):1887-1891.
  • 3Fadl-Elmula I, Gorunova L, Mandahl N, et al. Karyotypic characterization of urinary bladder transitional cell carci- nomas[J]. Genes Chromosomes Cancer,2000,29(3):256-265.
  • 4Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of a multi-target fluorescent in situ hybridiza- tion assay for detection of bladder cancer [J]. J Urol, 2002,168(5): 1950-1954.
  • 5Sarosdy MF, Kahn PR, Ziffer MD, et al. Use of a muhi- target fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria [J]. J Urol, 2006,176( 1 ):44-47.
  • 6Qin SL, Chen XJ, Xu X, et al. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comarative genomic hybridization [J]. Cancer Lett,2006,238(2):230-239.
  • 7Mostofi FK, Sorbin LH, Torloni H. Histologic typing of urinary bladder tumours [M]//Mostof FK. International classification of tumours. Geneva : WHO, 1973.
  • 8Sobin DH, Witteking Ch. TNM Classification of Malignant Tumours[M]. 6th ed. New York: Wiley-Liss,2002:199-200.
  • 9Hailing KC, Kipp BR. Bladder cancer detection using FISH (UroVysion Assay)[J]. Adv Anat Pathol,2008,15(5): 279-286.
  • 10Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RBI, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters [J]. J Clin Pathol,2005,58(4):367-371.

二级参考文献11

  • 1Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84: 587-597.
  • 2Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994, 368: 258-261.
  • 3Clifford SC, Prowse AH, Affara NA. Inactivation of the von Hippel-lindau(VHL) tumour suppressor gene and allellic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumorigenesis. Genes Chromosomes Cancer. 1998, 22: 200-209.
  • 4Mostofi FK, Davis CJ, Sesterhenn IA, et al. Histological typing of urinary bladder tumors. Berlin: Spring, 1999: 9-15.
  • 5Zhang J, Fan Z, Gao Y, et al. Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiological considerations. J Natl Cancer Inst, 2001, 93: 45-50.
  • 6Inoue H, Ishii H, Alder H, et al. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc Natl Acad Sci USA, 1997, 94: 14584-14589.
  • 7Wada T, Louhelainen J, Hemminki K, et al. The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction. BJU International , 2001, 87: 876-881.
  • 8Acopetta BJ, Soong R, House AK, et al. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes. J Pathol, 1999, 187: 428-432.
  • 9Atif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 1993, 260: 1317-1320.
  • 10Li M, Zhang ZF, Reuter VE, et al. Chromosome 3 allelic losses and microsatellite alterantions in transitional cell carcinoma of the urinary bladder. Am J Pathol 1996, 149: 229-235.

共引文献7

同被引文献64

  • 1穆大为,周利群,丁义,何志嵩,王莹,何群,杨新宇.应用荧光原位杂交技术检测膀胱尿路上皮癌的研究[J].中华临床医师杂志(电子版),2010,4(7):976-980. 被引量:5
  • 2张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 3董玉玮,邱龙,李培青,刘焕民,庞永红,朱必才.PCR和随机引物标记探针的方法比较[J].生物学杂志,2007,24(1):63-66. 被引量:7
  • 4许本波,谢伶俐,柴友荣,李加纳,田志宏.一种快速低廉的PCR探针标记方法[J].中国农学通报,2007,23(9):82-84. 被引量:3
  • 5Hailing KC, Kipp BR. Bladder cancer detection using FISH( UroVysion assay ) [ J ]. Adv Anat Patho1,2008,15 ( 5 ) :279 -286.
  • 6Lotan Y, Shariat SF, Sehmitz-Drager BJ, et al. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer[J]. Urol Oneol,2010,28(4) :441-448.
  • 7Skaeel M, Fahmy M, Brainard JA, et al. Muhitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the ma- jority of patients with bladder cancer and atypical or negative urine cytology[ J]. J Uro1,2003,169 (6) :2101-2105.
  • 8Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromo- some 17 and the 9p21 locus are independent predictors of tumor re- currence in non-invasive transitional cell carcinoma of the urinary bladder[J]. Int J Oncol,2003,23( 1 ) :4148.
  • 9Inoue T, Sato K, Tsuchiya N, et al. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated ceils from patients with urothelial carcinoma [ J ]. Urology,2004,64 (3) :617-621.
  • 10Fridman JS,Lowe SW. Control of apoptosis by p53[J]. Onco- gene,2003,22(56) :9030-9040.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部